$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 23.76 | 4,908 | 116,590 | 0 | |
| Aug 29 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 23.76 | 4,908 | 116,590 | 0 | |
| Aug 29 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Sell | S | 63.91 | 4,908 | 313,671 | 97,854 | 102.8 K to 97.9 K (-4.78 %) |
| Aug 29 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Sell | S | 63.91 | 4,908 | 313,671 | 97,854 | 102.8 K to 97.9 K (-4.78 %) |
| Aug 29 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 23.76 | 4,908 | 116,590 | 102,762 | 97.9 K to 102.8 K (+5.02 %) |
| Aug 29 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 23.76 | 4,908 | 116,590 | 102,762 | 97.9 K to 102.8 K (+5.02 %) |
| Aug 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Sell | S | 64.35 | 608 | 39,123 | 27,198 | 27.8 K to 27.2 K (-2.19 %) |
| Aug 13 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Option Exercise | M | 0.00 | 1,070 | 0 | 10,910 | |
| Aug 13 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Payment of Exercise | F | 65.24 | 462 | 30,141 | 27,806 | 28.3 K to 27.8 K (-1.63 %) |
| Aug 13 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Buy | M | 0.00 | 1,070 | 0 | 28,268 | 27.2 K to 28.3 K (+3.93 %) |
| Jul 26 2019 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 0.00 | 30,020 | 0 | 30,020 | |
| Jul 26 2019 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 66.64 | 148,110 | 9,870,050 | 148,110 | |
| Jul 25 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Option Exercise | M | 24.91 | 7,200 | 179,316 | 0 | |
| Jul 25 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Sell | S | 65.07 | 7,200 | 468,504 | 27,198 | 34.4 K to 27.2 K (-20.93 %) |
| Jul 25 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Buy | M | 24.91 | 7,200 | 179,316 | 34,398 | 27.2 K to 34.4 K (+26.47 %) |
| Jul 01 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 223 | 0 | 23,999 | |
| Jul 01 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 223 | 0 | 23,999 | |
| Jul 01 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 64 | 0 | 6,835 | |
| Jun 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Sell | S | 68.75 | 5,816 | 399,850 | 27,198 | 33 K to 27.2 K (-17.62 %) |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Payment of Exercise | F | 66.07 | 3,500 | 231,245 | 6,340 | 9.8 K to 6.3 K (-35.57 %) |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Grant | A | 0.00 | 9,840 | 0 | 9,840 | 0 to 9.8 K |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 4,553 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 4,553 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 6,794 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 10,164 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 2,270 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 6,298 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 2,270 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 66.07 | 11,848 | 782,797 | 11,848 | |
| May 10 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 0.00 | 2,270 | 0 | 2,270 | |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 0.00 | 2,283 | 0 | 0 | |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 0.00 | 2,283 | 0 | 97,854 | 95.6 K to 97.9 K (+2.39 %) |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | M | 0.00 | 2,283 | 0 | 0 | |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Payment of Exercise | F | 66.40 | 416 | 27,622 | 1,867 | 2.3 K to 1.9 K (-18.22 %) |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Buy | M | 0.00 | 2,283 | 0 | 2,283 | 0 to 2.3 K |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 0.00 | 2,283 | 0 | 4,028 | |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 0.00 | 2,283 | 0 | 27,418 | 25.1 K to 27.4 K (+9.08 %) |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 0.00 | 2,283 | 0 | 0 | |
| May 08 2019 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 0.00 | 2,283 | 0 | 126,782 | 124.5 K to 126.8 K (+1.83 %) |
| May 02 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 22.02 | 9,534 | 209,891 | 0 | |
| May 02 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 65.02 | 9,534 | 619,934 | 25,135 | 34.7 K to 25.1 K (-27.50 %) |
| May 02 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 22.02 | 9,534 | 209,891 | 34,669 | 25.1 K to 34.7 K (+37.93 %) |
| May 02 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 22.02 | 2,868 | 63,139 | 0 | |
| May 02 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 64.89 | 2,868 | 186,116 | 54,860 | 57.7 K to 54.9 K (-4.97 %) |
| May 02 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 22.02 | 2,868 | 63,139 | 57,728 | 54.9 K to 57.7 K (+5.23 %) |
| Apr 25 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | M | 24.91 | 13,208 | 328,945 | 0 | |
| Apr 25 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Buy | M | 24.91 | 13,208 | 328,945 | 43,332 | 30.1 K to 43.3 K (+43.85 %) |
| Apr 25 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 22.02 | 2,700 | 59,441 | 2,868 | |
| Apr 25 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 62.61 | 2,700 | 169,054 | 54,860 | 57.6 K to 54.9 K (-4.69 %) |
| Apr 25 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 22.02 | 2,700 | 59,441 | 57,560 | 54.9 K to 57.6 K (+4.92 %) |
| Apr 18 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 22.02 | 2,700 | 59,441 | 5,568 | |
| Apr 18 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 64.66 | 100 | 6,466 | 54,860 | 55 K to 54.9 K (-0.18 %) |
| Apr 18 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 64.21 | 2,600 | 166,958 | 54,960 | 57.6 K to 55 K (-4.52 %) |
| Apr 18 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 22.02 | 2,700 | 59,441 | 57,560 | 54.9 K to 57.6 K (+4.92 %) |
| Apr 12 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 22.02 | 2,700 | 59,441 | 8,268 | |
| Apr 12 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 67.23 | 2,700 | 181,521 | 54,860 | 57.6 K to 54.9 K (-4.69 %) |
| Apr 12 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 22.02 | 2,700 | 59,441 | 57,560 | 54.9 K to 57.6 K (+4.92 %) |
| Apr 04 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 22.02 | 2,700 | 59,441 | 10,968 | |
| Apr 04 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 66.74 | 2,700 | 180,198 | 54,860 | 57.6 K to 54.9 K (-4.69 %) |
| Apr 04 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 22.02 | 2,700 | 59,441 | 57,560 | 54.9 K to 57.6 K (+4.92 %) |
| Apr 02 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 22.02 | 9,534 | 209,891 | 9,534 | |
| Apr 02 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 65.48 | 9,534 | 624,255 | 25,135 | 34.7 K to 25.1 K (-27.50 %) |
| Apr 02 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 22.02 | 9,534 | 209,891 | 34,669 | 25.1 K to 34.7 K (+37.93 %) |
| Apr 01 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 233 | 0 | 23,776 | |
| Apr 01 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 66 | 0 | 6,771 | |
| Mar 28 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 22.02 | 2,700 | 59,441 | 13,668 | |
| Mar 28 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 64.14 | 2,700 | 173,178 | 54,860 | 57.6 K to 54.9 K (-4.69 %) |
| Mar 28 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 22.02 | 2,700 | 59,441 | 57,560 | 54.9 K to 57.6 K (+4.92 %) |
| Mar 21 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 22.02 | 2,700 | 59,441 | 16,368 | |
| Mar 21 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 65.07 | 2,700 | 175,689 | 54,860 | 57.6 K to 54.9 K (-4.69 %) |
| Mar 21 2019 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 22.02 | 2,700 | 59,441 | 57,560 | 54.9 K to 57.6 K (+4.92 %) |
| Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | J | 0.00 | 330 | 0 | 117,323 | 117 K to 117.3 K (+0.28 %) |
| Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | J | 0.00 | 330 | 0 | 21,620 | 22 K to 21.6 K (-1.50 %) |
| Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 57.45 | 330 | 18,959 | 21,950 | 21.6 K to 22 K (+1.53 %) |
| Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | J | 0.00 | 11,588 | 0 | 116,993 | 105.4 K to 117 K (+10.99 %) |
| Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | J | 0.00 | 11,588 | 0 | 21,620 | 33.2 K to 21.6 K (-34.90 %) |
| Mar 14 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Grant | A | 57.45 | 330 | 18,959 | 33,014 | 32.7 K to 33 K (+1.01 %) |
| Mar 05 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | Chief Patient Offic ... | Option Exercise | A | 0.00 | 1,890 | 0 | 15,530 | |
| Mar 05 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | Chief Patient Offic ... | Option Exercise | A | 66.01 | 9,640 | 636,336 | 9,640 | |
| Mar 05 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | Chief Patient Offic ... | Grant | A | 57.45 | 330 | 18,959 | 58,046 | 57.7 K to 58 K (+0.57 %) |
| Mar 05 2019 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 0.00 | 128,770 | 0 | 174,220 | |
| Mar 05 2019 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 0.00 | 45,450 | 0 | 45,450 | |
| Mar 05 2019 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 66.01 | 231,280 | 15,266,793 | 231,280 | |
| Feb 20 2019 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 22.02 | 19,068 | 419,782 | 0 | |
| Feb 20 2019 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Sell | S | 67.08 | 19,068 | 1,279,074 | 124,499 | 143.6 K to 124.5 K (-13.28 %) |
| Feb 20 2019 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 0.00 | 19,068 | 0 | 143,567 | 124.5 K to 143.6 K (+15.32 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Option Exercise | A | 0.00 | 14,550 | 0 | 16,015 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Option Exercise | A | 68.75 | 67,310 | 4,627,563 | 67,310 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Payment of Exercise | F | 68.75 | 4,453 | 306,144 | 37,828 | 42.3 K to 37.8 K (-10.53 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Grant | A | 0.00 | 7,104 | 0 | 42,281 | 35.2 K to 42.3 K (+20.20 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Grant | A | 0.00 | 8,323 | 0 | 35,177 | 26.9 K to 35.2 K (+30.99 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 0.00 | 14,550 | 0 | 14,550 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 68.75 | 67,310 | 4,627,563 | 67,310 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 68.75 | 5,535 | 380,531 | 33,208 | 38.7 K to 33.2 K (-14.29 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 8,270 | 0 | 38,743 | 30.5 K to 38.7 K (+27.14 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 13,312 | 0 | 30,473 | 17.2 K to 30.5 K (+77.57 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Option Exercise | A | 0.00 | 10,910 | 0 | 11,980 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Option Exercise | A | 68.75 | 50,480 | 3,470,500 | 50,480 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Payment of Exercise | F | 68.75 | 3,871 | 266,131 | 32,684 | 36.6 K to 32.7 K (-10.59 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Grant | A | 0.00 | 6,463 | 0 | 36,555 | 30.1 K to 36.6 K (+21.48 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Grant | A | 0.00 | 9,386 | 0 | 30,092 | 20.7 K to 30.1 K (+45.33 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Option Exercise | A | 0.00 | 13,640 | 0 | 46,435 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Option Exercise | A | 68.75 | 63,100 | 4,338,125 | 63,100 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Option Exercise | A | 0.00 | 13,640 | 0 | 13,640 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Option Exercise | A | 68.75 | 63,100 | 4,338,125 | 63,100 | |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Payment of Exercise | F | 68.75 | 5,861 | 402,944 | 57,716 | 63.6 K to 57.7 K (-9.22 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 0.00 | 9,042 | 0 | 63,577 | 54.5 K to 63.6 K (+16.58 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 0.00 | 10,109 | 0 | 54,535 | 44.4 K to 54.5 K (+22.75 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Payment of Exercise | F | 68.75 | 13,787 | 947,856 | 2,887,225 | 2.9 M to 2.9 M (-0.48 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 15,505 | 0 | 2,901,012 | 2.9 M to 2.9 M (+0.54 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 7,745 | 0 | 2,885,507 | 2.9 M to 2.9 M (+0.27 %) |
| Feb 01 2019 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | M | 0.00 | 480 | 0 | 2,283 | |
| Feb 01 2019 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Buy | M | 0.00 | 480 | 0 | 13,740 | 13.3 K to 13.7 K (+3.62 %) |
| Jan 02 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 61 | 0 | 6,705 | |
| Jan 02 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 215 | 0 | 23,543 | |
| Dec 19 2018 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Payment of Exercise | F | 65.12 | 2,988 | 194,579 | 26,854 | 29.8 K to 26.9 K (-10.01 %) |
| Dec 19 2018 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Grant | A | 0.00 | 6,135 | 0 | 29,842 | 23.7 K to 29.8 K (+25.88 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 0 | |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 72.67 | 200 | 14,533 | 2,877,762 | 2.9 M to 2.9 M (-0.01 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 71.95 | 13,958 | 1,004,275 | 2,877,962 | 2.9 M to 2.9 M (-0.48 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.90 | 35,842 | 2,541,370 | 2,891,920 | 2.9 M to 2.9 M (-1.22 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 2,927,762 | 2.9 M to 2.9 M (+1.74 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Gift | G | 0.00 | 140,000 | 0 | 2,877,762 | 3 M to 2.9 M (-4.64 %) |
| Nov 29 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 23.60 | 280,000 | 6,608,000 | 0 | |
| Nov 29 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 23.60 | 280,000 | 6,608,000 | 1,574,306 | 1.3 M to 1.6 M (+21.63 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 50,000 | |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.15 | 13,579 | 952,632 | 3,017,762 | 3 M to 3 M (-0.45 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 69.53 | 28,421 | 1,976,135 | 3,031,341 | 3.1 M to 3 M (-0.93 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 68.61 | 8,000 | 548,850 | 3,059,762 | 3.1 M to 3.1 M (-0.26 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Oct 09 2018 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Option Exercise | A | 0.00 | 32,795 | 0 | 32,795 | |
| Oct 09 2018 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Option Exercise | A | 0.00 | 32,795 | 0 | 32,795 | |
| Oct 09 2018 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Option Exercise | A | 76.24 | 87,680 | 6,684,723 | 87,680 | |
| Oct 09 2018 | GILD | GILEAD SCIENCES IN ... | Hamill Laura | EVP, Worldwide Comm ... | Option Exercise | A | 76.24 | 87,680 | 6,684,723 | 87,680 | |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 100,000 | |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 78.34 | 16,670 | 1,305,853 | 3,017,762 | 3 M to 3 M (-0.55 %) |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 77.90 | 33,330 | 2,596,357 | 3,034,432 | 3.1 M to 3 M (-1.09 %) |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Oct 01 2018 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 49 | 0 | 6,644 | |
| Oct 01 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 172 | 0 | 23,328 | |
| Sep 19 2018 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Grant | A | 63.61 | 94 | 5,980 | 20,706 | 20.6 K to 20.7 K (+0.46 %) |
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 150,000 | |
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 75.00 | 2,624 | 196,790 | 3,017,762 | 3 M to 3 M (-0.09 %) |